Price, D., Henley, W., Delfini Cançado, J. E., Fabbri, L. M., Kerstjens, H. A., Papi, A., . . . Georges, G. (2024). Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS.
Citación estilo ChicagoPrice, David, et al. Risk of Pneumonia in Patients With COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate Versus Patients Initiating LABD Without ICS. 2024.
Cita MLAPrice, David, et al. Risk of Pneumonia in Patients With COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate Versus Patients Initiating LABD Without ICS. 2024.